Results 141 to 150 of about 53,999 (225)

How Duffy Blood Group (FY) Polymorphism and Age Modulate Vivax Malaria Risk at the Community Level: A Population-based Retrospective Cohort Study in the Amazon. [PDF]

J Infect Dis
Prete CA, de Sousa TN, Naziazeno IM, Puça MCSB, Ladeia WA, Rodrigues PT, Johansen IC, Paula GA, Ferreira MU, Corder RM, Mâncio Lima Cohort Study Working Group .   +10 more
europepmc   +1 more source

Efficacy of Primaquine for the Radical Cure of Plasmodium vivax Malaria in Northeast Myanmar and the Impact of Cytochrome P450 2D6 Genotypes. [PDF]

Clin Infect Dis
Zeng W, Liu H, Malla P, Zhao Y, Menezes L, Cao Y, Wang C, Yang Z, Cui L.   +8 more
europepmc   +1 more source

Underlying Chronic Lymphocytic Leukemia in a Case of Vivax Malaria With Thrombocytopenia: A Case Report. [PDF]

Cureus
Saha A, Mukhopadhyay M, Talapatra A, Bandhopadhay T, Sardar S.   +4 more
europepmc   +1 more source

Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination. [PDF]

Sci Rep
Wongsurawat T, Jenjaroenpun P, Suwannasin K, Wankaew N, Sanguansakpakdee N, Amornpornviwat T, Dondorp AM, Day NPJ, Nosten F, White NJ, Imwong M.   +10 more
europepmc   +1 more source

Reduced Red Blood Cell Deformability in Vivax Malaria. [PDF]

J Infect Dis
Rathnam JTT, Grigg MJ, Dondorp AM, William T, Rajasekhar M, Rajahram G, Simpson JA, Barber BE, Anstey NM.   +8 more
europepmc   +1 more source

The cost-effectiveness of tafenoquine following screening with STANDARD™ G6PD screening for the treatment of vivax malaria in the Brazilian Public Health System. [PDF]

Lancet Reg Health Am
Peixoto HM, Bastos Gottin LL, Brito-Sousa JD, Sampaio V, Daumerie PG, Jambert E, Monteiro W, Lacerda MVG, Devine A.   +8 more
europepmc   +1 more source

Safety and Efficacy of 3 Alternative Regimens Against Relapsing Plasmodium vivax Malaria in Glucose 6-Phosphate Dehydrogenase-Deficient Patients in the Brazilian Amazon (ALTPRIM). [PDF]

Clin Infect Dis
Barbosa L, Brito-Sousa J, Nascimento C, Pacheco A, Alexandre M, Alencar A, Melo M, Omena A, Souza I, Silva E, Queiroz M, Siqueira V, Rabelo C, Baía-da-Silva D, Silva D, Rocha Y, Barbosa A, Castro R, Almeida A, Brito M, Lopes A, Balieiro A, Costa M, Amaral T, Valle C, Vieira A, Gonzaga J, Pereira D, Alecrim M, Monteiro W, Lacerda M, Melo G.   +31 more
europepmc   +1 more source

Preliminary assessment of serum endocan as a biomarker of disease severity in Plasmodium falciparum and Plasmodium vivax malaria. [PDF]

Malar J
Nantavisai K, Puttikamonkul S, Viriyavejakul P.   +2 more
europepmc   +1 more source

Slide positivity, trends, and risk factors of febrile Plasmodium vivax malaria along the Thailand-Myanmar border, 2018-2023. [PDF]

Infect Dis Poverty
Aung PL, Rachaphaew N, Sripoorote P, Htwe KZZ, Suk-Aum K, Kaewkungwal J, Lawpoolsri S, Cui L, Sattabongkot J.   +8 more
europepmc   +1 more source

Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis. [PDF]

Malar J
Edler P, Rajasekhar M, Price DJ, Adam I, Awab GR, Barber BE, Brasil LW, Chamma-Siqueira NN, Chu CS, Cui L, Daher A, Gomes MDSM, Gonzalez-Ceron L, Grigg MJ, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Ley B, Lidia K, Llanos-Cuentas A, Longley RJ, Manning L, Mekonnen DA, Monteiro WM, Moore BR, Nosten F, Pasaribu AP, Pereira DB, Poespoprodjo JR, Pukrittayakamee S, Rijal KR, Saravu K, Siqueira AM, Sutanto I, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Yeshiwondim AK, Zuluaga-Idarraga LM, Guerin PJ, Simpson JA, Price RN, Commons RJ, WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group.   +47 more
europepmc   +1 more source